Sponsor of the Day:
Jerkmate
https://springworkstx.com/pipeline/mirdametinib/
Mirdametinib - NF1 Treatment - SpringWorks Therapeutics
Feb 28, 2025 - Mirdametinib is an oral small molecule designed to inhibit MEK1 and MEK2, which are proteins that occupy pivotal positions in the MAPK pathway.
springworks therapeuticsmirdametinibnf1treatment
https://springworkstx.com/
SpringWorks Therapeutics - Unlocking Targeted Oncology
Oct 22, 2025 - We relentlessly pursue every possibility to create new cancer breakthroughs and power our approach with people who think hard, care hard, and act with urgency....
springworks therapeuticsunlockingtargetedoncology
https://www.greatplacetowork.com/certified-company/7039053
Working at SpringWorks Therapeutics | Great Place To Work®
Is SpringWorks Therapeutics a great place to work for?
springworks therapeuticsgreat placeworking
https://springworkstx.com/patients/neurofibromatosis-type-1/
NF1 Plexiform Neurofibroma Trial - SpringWorks Therapeutics
May 12, 2025 - When there are no approved treatments for a condition, we must develop them. Clinical trials are studies that collect data to determine if a new drug is safe...
springworks therapeuticsnf1trial